PDPL

Parenteral Drugs (India) Limited has submitted to the Exchange a copy of newspaper clippings of un-audited financial results for the quarter ended December 31, 2019 published pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parenteral Drugs (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Parenteral Drugs (India) Limited has submitted to the Exchange a copy of disclosure of Related Party Transactions under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2019.

Parenteral Drugs (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Parenteral Drugs (India) Limited has informed the Exchange regarding Disclosure of Related Party Transactions as per Regulation 23 (9) of SEBI (LODR) Regulations, 2019 for the half year ended March 31, 2019

Parenteral Drugs (India) Limited has informed the Exchange regarding the Code of Conduct under SEBI(PIT) Reg., 2015

Parenteral Drugs (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Parenteral Drugs (India) Limited has informed the Exchange that As per the provisions of regulation 9 and Schedule B of the SEBI (Prohibition of Insider Trading) Regulations, 2015, in respect of Company s Code of Conduct to regulate, monitor and report trading by insiders for Prevention of Insider Trading in the Equity shares and for the aforesaid purpose the "Trading Window" of the Company shall remain closed from the date of intimation i.e. May 21, 2016 to June 01, 2016 and will open on June 02, 2016 for insiders accordingly.

Parenteral Drugs (India) Limited has informed the Exchange that As per the provisions of regulation 9 and Schedule B of the SEBI (Prohibition of Insider Trading) Regulations, 2015, in respect of Company's Code of Conduct to regulate, monitor and report trading by insiders for Prevention of Insider Trading in the Equity shares and for the aforesaid purpose the "Trading Window" of the Company shall remain closed from the date of intimation i.e. February 04, 2016 to February 15, 2016 and will open on February 16, 2016 for insiders accordingly.

Parenteral Drugs (India) Limited has informed the Exchange that the "Trading Window" of the Company shall remain closed from the date of intimation i.e. December 26, 2015 to January 01, 2016 and will open on January 02, 2016 for insiders accordingly.

Parenteral Drugs (India) Limited has informed the Exchange that the "Trading Window" of the Company shall remain closed from October 31, 2015 to November 11, 2015 and will open on November 12, 2015 for insiders accordingly.

Parenteral Drugs (India) Limited has informed the Exchange that the "Trading Window'' of the Company shall remain closed from September 22, 2015 to October 2, 2015 and will open on October 3, 2015 for insiders accordingly

Parenteral Drugs (India) Limited has informed the Exchange that in respect of Company s Code of Conduct to regulate, monitor and report trading by insiders for Prevention of Insider Trading in the Equity shares and for the aforesaid purpose the "Trading Window" of the Company shall remain closed from the date of intimation i.e. July 09, 2015 to July 20, 2015 and will open on July 21, 2015 for insiders accordingly

Parenteral Drugs (India) Limited has informed the Exchange regarding the Code of Practices, procedure and code of conduct to regulate, monitor and report trading in securities and fair disclosure of unpublished price sensitive information pursuant to the requirements of the securities and exchange board of india (prohibition of insider trading) Regulations, 2015.

Parenteral Drugs (India) Limited has informed the Exchange that the "Trading Window" of the Company shall remain closed from May 29, 2015 to June 1, 2015 and will open on June 2, 2015 for insiders accordingly.

Parenteral Drugs (India) Limited has informed the Exchange that as per Regulation 12 of the SEBI (Prohibition of Insider Trading) Regulations, 1992, in respect of Company's Code of Conduct for Prevention of Insider Trading in the Equity shares, it is hereby informed that for the purpose Board Meeting "Trading Window" of the Company shall remain closed from March 28, 2015 to March 31, 2015 and will open on April 1, 2015 for insiders accordingly.

Parenteral Drugs (India) Limited has informed the Exchange that a meeting of the Board of Directors of the Company will be held on Tuesday, the February 10, 2015 at 11.30 a.m. and for this purpose "Trading Window" of the Company shall remain closed from February 09, 2015 to February 11, 2015 and will open on February 12, 2015 for insiders accordingly.

Parenteral Drugs (India) Limited has informed the Exchange that as per Regulation 12 of the SEBI (Prohibition of Insider Trading) Regulations, 1992, in respect of Company's Code of Conduct for Prevention of Insider Trading in the Equity shares, it is hereby informed that a meeting of the Board of Directors of the Company will be held on November 14, 2014 and for this purpose "Trading Window" of the Company shall remain closed from November 12, 2014 to November 16, 2014 and will open on November 17, 2014 for insiders accordingly.